Annual ROE
-67.00%
+18.34%+21.49%
June 30, 2024
Summary
- As of February 27, 2025, RENB annual return on equity is -67.00%, with the most recent change of +18.34% (+21.49%) on June 30, 2024.
- During the last 3 years, RENB annual ROE has fallen by -51.70% (-337.91%).
- RENB annual ROE is now -130.70% below its all-time high of 218.25%, reached on March 1, 2012.
Performance
RENB ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-105.00%
+6.67%+5.97%
December 31, 2024
Summary
- As of February 27, 2025, RENB quarterly return on equity is -105.00%, with the most recent change of +6.67% (+5.97%) on December 31, 2024.
- Over the past year, RENB quarterly ROE has dropped by -14.52% (-16.05%).
- RENB quarterly ROE is now -112.74% below its all-time high of 824.30%, reached on September 1, 2016.
Performance
RENB Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
RENB ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.5% | -16.1% |
| 3 y3 years | -337.9% | -16.1% |
| 5 y5 years | -543.6% | -16.1% |
RENB ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -337.9% | +57.1% | -357.9% | +32.1% |
| 5 y | 5-year | -875.3% | +57.1% | -2833.0% | +32.1% |
| alltime | all time | -130.7% | +91.5% | -112.7% | +93.1% |
Renovaro Biosciences ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | -105.00%(-6.0%) |
| Sep 2024 | - | -111.67%(+23.4%) |
| Jun 2024 | -67.00%(-21.5%) | -90.48%(-28.0%) |
| Mar 2024 | - | -125.58%(+54.6%) |
| Dec 2023 | - | -81.25%(+11.7%) |
| Sep 2023 | - | -72.76%(+14.5%) |
| Jun 2023 | -85.34%(-45.4%) | - |
| Jun 2023 | - | -63.53%(-58.9%) |
| Mar 2023 | - | -154.69%(+32.1%) |
| Dec 2022 | - | -117.06%(+24.2%) |
| Sep 2022 | - | -94.27%(+17.7%) |
| Jun 2022 | -156.20%(+920.9%) | -80.10%(+230.0%) |
| Mar 2022 | - | -24.27%(+5.8%) |
| Dec 2021 | - | -22.93%(+9.9%) |
| Sep 2021 | - | -20.87%(+29.5%) |
| Jun 2021 | -15.30%(+122.7%) | -16.12%(+96.1%) |
| Mar 2021 | - | -8.22%(+24.4%) |
| Dec 2020 | - | -6.61%(+14.2%) |
| Sep 2020 | - | -5.79%(-13.8%) |
| Jun 2020 | -6.87%(-34.0%) | -6.72%(+87.7%) |
| Mar 2020 | - | -3.58%(-19.7%) |
| Dec 2019 | - | -4.46%(-67.3%) |
| Sep 2019 | - | -13.64%(+17.2%) |
| Jun 2019 | -10.41%(+161.6%) | -11.64%(-17.1%) |
| Mar 2019 | - | -14.04%(-1.2%) |
| Dec 2018 | - | -14.21%(+152.4%) |
| Sep 2018 | - | -5.63%(-31.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | -3.98%(-97.2%) | -8.23%(-30.8%) |
| Mar 2018 | - | -11.90%(-92.2%) |
| Dec 2017 | - | -152.73%(-66.0%) |
| Sep 2017 | - | -449.40%(-213.0%) |
| Jun 2017 | -139.81%(-82.3%) | 397.64%(+58.5%) |
| Mar 2017 | - | 250.93%(-34.7%) |
| Dec 2016 | - | 384.48%(-53.4%) |
| Sep 2016 | - | 824.30%(-154.4%) |
| Jun 2016 | -789.21%(+218.0%) | -1515.55%(+464.9%) |
| Mar 2016 | - | -268.31%(+69.1%) |
| Dec 2015 | - | -158.64%(+42.1%) |
| Sep 2015 | - | -111.63%(-90.1%) |
| Jun 2015 | -248.20%(+264.5%) | - |
| Mar 2015 | - | -1125.12%(-538.5%) |
| Dec 2014 | -68.09%(-192.9%) | 256.61%(+224.3%) |
| Sep 2014 | - | 79.12%(+6.7%) |
| Jun 2014 | - | 74.14%(-2.4%) |
| Mar 2014 | - | 75.98%(+29.0%) |
| Dec 2013 | - | 58.91%(-17.4%) |
| Sep 2013 | - | 71.29%(+8.0%) |
| Jun 2013 | - | 66.00%(-34.5%) |
| Mar 2013 | 73.29%(-66.4%) | 100.74%(-12.9%) |
| Dec 2012 | - | 115.67%(-32.3%) |
| Sep 2012 | - | 170.78%(-33.8%) |
| Jun 2012 | - | 257.86%(-1.2%) |
| Mar 2012 | 218.25% | 260.87%(-5.2%) |
| Dec 2011 | - | 275.27% |
FAQ
- What is Renovaro Biosciences annual return on equity?
- What is the all time high annual ROE for Renovaro Biosciences?
- What is Renovaro Biosciences annual ROE year-on-year change?
- What is Renovaro Biosciences quarterly return on equity?
- What is the all time high quarterly ROE for Renovaro Biosciences?
- What is Renovaro Biosciences quarterly ROE year-on-year change?
What is Renovaro Biosciences annual return on equity?
The current annual ROE of RENB is -67.00%
What is the all time high annual ROE for Renovaro Biosciences?
Renovaro Biosciences all-time high annual return on equity is 218.25%
What is Renovaro Biosciences annual ROE year-on-year change?
Over the past year, RENB annual return on equity has changed by +18.34% (+21.49%)
What is Renovaro Biosciences quarterly return on equity?
The current quarterly ROE of RENB is -105.00%
What is the all time high quarterly ROE for Renovaro Biosciences?
Renovaro Biosciences all-time high quarterly return on equity is 824.30%
What is Renovaro Biosciences quarterly ROE year-on-year change?
Over the past year, RENB quarterly return on equity has changed by -14.52% (-16.05%)